Please use this identifier to cite or link to this item:
Title: Rare diseases and orphan drug availability in Malta
Authors: Abbas, Amar
Vella Szijj, Janis
Serracino-Inglott, Anthony
Keywords: Orphan drugs -- Malta
Rare diseases -- Treatment
Pharmaceutical policy -- Malta
Issue Date: 2018-11
Publisher: University of Malta. Department of Pharmacy
Citation: Abbas, A., Vella Szijj, J., & Serracino-Inglott, A. (2018, November). Rare diseases and orphan drug availability in Malta. Poster session presented at the X Malta Medical School Conference, St Julian's, Malta.
Abstract: A poster presentation regarding rare diseases and orphan drug availability in Malta. Aims: Over 7000 rare diseases (RD) affect around 60 million patients in the European Union and the United States (US). ‘RD-action’ is a European Health Programme funded Joint Action which provides information and data on RDs. The aims of the study were to describe orphan drug (OD) availability and the health needs of the Maltese RD population.
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Rare_diseases _and _orphan_drug_availability_in_Malta_2018.pdf390.11 kBAdobe PDFView/Open

Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.